1. |
中华医学会眼科学分会眼免疫学组, 中国医师协会眼科医师分会葡萄膜炎与免疫学组. 中国Fuchs葡萄膜炎综合征临床诊疗专家共识(2022年)[J]. 中华眼科杂志, 2022, 58(7): 500-505. DOI: 10.3760/cma.j.cn112142-20220124-00030.Ocular Immunology Group, Chinese Society of Ophthalmology, Chinese Medical Association, Uveitis and Immunology Group, Chinese Ophthalmologist Association, Chinese Medical Doctor Association. Chinese expert consensus on clinical diagnosis and management of fuchs uveitis syndrome (2022)[J]. Chin J Ophthalmol, 2022, 58(7): 500-505. DOI: 10.3760/cma.j.cn112142-20220124-00030.
|
2. |
Yang P, Zhang W, Chen Z, et al. Development of revised diagnostic criteria for Fuchs' uveitis syndrome in a Chinese population[J]. Br J Ophthalmol, 2022, 106(12): 1678-1683. DOI: 10.1136/bjophthalmol-2021-319343.
|
3. |
Liu H, Lai Y, Liu Y, et al. Clinical characteristics of viral-associated Fuchs uveitis syndrome and Posner-Schlossman syndrome in a Chinese population[J]. Graefe's Arch Clin Exp Ophthalmol, 2024, 262(10): 3305-3312. DOI: 10.1007/s00417-024-06502-0.
|
4. |
Brichová M, Lízrová JP, Heissigerová J, et al. Association of fuchs heterochromic iridocyclitis with multiple sclerosis[J]. Cesk Slov Oftalmol, 2024, 80(4): 188-192. DOI: 10.31348/2024/17.
|
5. |
Sun Y, Ji Y. A literature review on Fuchs uveitis syndrome: an update[J]. Surv Ophthalmol, 2020, 65(2): 133-143. DOI: 10.1016/j.survophthal.2019.10.003.
|
6. |
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for Fuchs uveitis syndrome[J]. Am J Ophthalmol, 2021, 228: 262-267. DOI: 10.1016/j.ajo.2021.03.052.
|
7. |
Kawali A, Sriram R, Srinivasan S, et al. Evolving Fuchs' uveitis-a diagnostic challenge[J]. Indian J Ophthalmol, 2024, 72(6): 885-889. DOI: 10.4103/IJO.IJO_1151_23.
|
8. |
Yoneda Y, Usui Y, Tanaka R, et al. Factors associated with low prevalence of Fuchs' uveitis syndrome in Japan[J/OL]. Front Med (Lausanne), 2022, 9: 999804[2022-09-30]. https://pubmed.ncbi.nlm.nih.gov/36250082/. DOI: 10.3389/fmed.2022.999804.
|
9. |
Kianersi F, Kianersi H, Pourazizi M, et al. Fuchs' uveitis syndrome: a 20-year experience in 466 patients[J/OL]. Sci Rep, 2024, 14(1): 8621[2024-04-14]. https://pubmed.ncbi.nlm.nih.gov/38616214/. DOI: 10.1038/s41598-024-59393-w.
|
10. |
Rosenbaum JT, Pasadhika S. Ocular sarcoidosis[J]. Clin Chest Med, 2024, 45(1): 59-70. DOI: 10.1016/j.ccm.2023.08.003.
|
11. |
Tsui JK, Poon SHL, Fung NSK. Ocular manifestations and diagnosis of tuberculosis involving the uvea: a case series[J]. Trop Dis Travel Med Vaccines, 2023, 9(1): 20. DOI: 10.1186/s40794-023-00205-w.
|
12. |
Zarei M, Darabeigi S, Mehrpour M, et al. Fuchs' uveitis in Iranian patients: a review of 89 eyes[J]. Ocul Immunol Inflamm, 2019, 27(7): 1077-1085. DOI: 10.1080/09273948.2018.1500612.
|
13. |
Nalçacıoğlu P, Çakar Özdal P, Şimşek M. Clinical characteristics of Fuchs' uveitis syndrome[J]. Turk J Ophthalmol, 2016, 46(2): 52-57. DOI: 10.4274/tjo.99897.
|